4-methyl-3-(phenylsulfonyl)furoxan has been researched along with l 660,711 in 1 studies
| Studies (4-methyl-3-(phenylsulfonyl)furoxan) | Trials (4-methyl-3-(phenylsulfonyl)furoxan) | Recent Studies (post-2010) (4-methyl-3-(phenylsulfonyl)furoxan) | Studies (l 660,711) | Trials (l 660,711) | Recent Studies (post-2010) (l 660,711) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 45 | 0 | 12 |
| Protein | Taxonomy | 4-methyl-3-(phenylsulfonyl)furoxan (IC50) | l 660,711 (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 9.3 | |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 8 | |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | 2.9 | |
| Bile salt export pump | Homo sapiens (human) | 3.515 | |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 2.9733 | |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | 2.62 | |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | 7 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 6.4 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 4.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berardi, F; Chegaev, K; Colabufo, NA; Crosetti, M; Fruttero, R; Gasco, A; Guglielmo, S; Niso, M; Panaro, MA; Perrone, R | 1 |
1 other study(ies) available for 4-methyl-3-(phenylsulfonyl)furoxan and l 660,711
| Article | Year |
|---|---|
Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Proliferation; Dogs; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Oxadiazoles; Structure-Activity Relationship; Sulfones | 2010 |